Shuttle Pharmaceuticals Holdings (SHPH) said in a filing with the US Securities and Exchange Commission that it is offering common shares, pre-funded warrants to buy shares, and warrants to purchase shares.
The company did not disclose the terms of the offering including pricing and number of shares, pre-funded warrants and warrants.
Shuttle plans to use the net proceeds from the offering to fund trials of product candidates, and pay $2.3 million owed to clinical research organization Theradex Systems.
Shares of Shuttle Pharmaceuticals were down nearly 6% in recent trading.
Price: 1.53, Change: -0.09, Percent Change: -5.68
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。